BALY vs VRTX · rev $1.55B vs P/E 30, rev $3.33B
Bally's Corp (BALY) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Bally's Corp (BALY) is a resorts & casinos company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BALY revenue for 2026-06-30 was $1.55B. Net income was -$308.0M. BALY currently screens at market cap $661.8M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BALY currently screens at market cap $661.8M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BALY and VRTX stock pages for the full models.
Not investment advice.